Related Experiment Video
Updated: Aug 14, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
LOW-DOSE ASPIRIN USE TO PREVENT COLORECTAL CANCER AND CARDIOVASCULAR DISEASE: AN UPDATE
Linda Morrow1,2, Beverly Greenwald1,2
1Linda Morrow, DNP, MSN, MBA, NE-BC, CPHQ, CNOR, RN, is Program Director, Nursing Management and Executive Leadership, Clinical Associate Professor of Nursing, Dr. Susan L. Davis & Richard J. Henley College of Nursing, Sacred Heart University, Fairfield, Connecticut.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cancer Prevention
Some...
Coronary Artery Disease IV: Preventive Measures
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drugs for Treatment of Ulcerative Colitis in IBD

